Skip to content
10-Q

Quarterly Report

Akero Therapeutics, Inc.

0001193125-25-272569

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 82.32M sh
Shares Diluted Q3 2025 · Sep 30, 2025 82.01M sh
Shares Diluted Q3 2025 · Sep 30, 2025 80.81M sh
Shares Diluted Q3 2025 · Sep 30, 2024 69.44M sh
Shares Diluted Q3 2025 · Sep 30, 2024 65.98M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$183.08M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$163.02M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $176.03M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $340.24M
Stockholders Equity Q3 2025 · Sep 30, 2025 $957.64M
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.03B
Stockholders Equity Q3 2025 · Mar 31, 2025 $1.08B
Stockholders Equity Q3 2025 · Dec 31, 2024 $750.11M
Stockholders Equity Q3 2025 · Sep 30, 2024 $738.33M
Stockholders Equity Q3 2025 · Jun 30, 2024 $798.07M
Stockholders Equity Q3 2025 · Mar 31, 2024 $846.25M
Stockholders Equity Q3 2025 · Dec 31, 2023 $535.31M
Current Liabilities Q3 2025 · Sep 30, 2025 $47.65M
Current Liabilities Q3 2025 · Dec 31, 2024 $39.75M
Total Liabilities Q3 2025 · Sep 30, 2025 $47.94M
Total Liabilities Q3 2025 · Dec 31, 2024 $75.77M
Current Assets Q3 2025 · Sep 30, 2025 $754.54M
Current Assets Q3 2025 · Dec 31, 2024 $770.38M
Total Assets Q3 2025 · Sep 30, 2025 $1.01B
Total Assets Q3 2025 · Dec 31, 2024 $825.89M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.99
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.76
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.05
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.76
Eps Basic Q3 2025 · Sep 30, 2025 −$0.99
Eps Basic Q3 2025 · Sep 30, 2025 −$2.76
Eps Basic Q3 2025 · Sep 30, 2024 −$1.05
Eps Basic Q3 2025 · Sep 30, 2024 −$2.76
Sga Expense Q3 2025 · Sep 30, 2025 $11.35M
Sga Expense Q3 2025 · Sep 30, 2025 $34.29M
Sga Expense Q3 2025 · Sep 30, 2024 $9.47M
Sga Expense Q3 2025 · Sep 30, 2024 $29.19M
Rd Expense Q3 2025 · Sep 30, 2025 $78.88M
Rd Expense Q3 2025 · Sep 30, 2025 $217.7M
Rd Expense Q3 2025 · Sep 30, 2024 $72.23M
Rd Expense Q3 2025 · Sep 30, 2024 $178.2M
Net Income Q3 2025 · Sep 30, 2025 −$81.57M
Net Income Q3 2025 · Sep 30, 2025 −$222.8M
Net Income Q3 2025 · Jun 30, 2025 −$70.51M
Net Income Q3 2025 · Mar 31, 2025 −$70.73M
Net Income Q3 2025 · Dec 31, 2024 −$252.06M
Net Income Q3 2025 · Sep 30, 2024 −$72.71M
Net Income Q3 2025 · Sep 30, 2024 −$182.04M
Net Income Q3 2025 · Jun 30, 2024 −$55.99M
Net Income Q3 2025 · Mar 31, 2024 −$53.34M
Net Income Q3 2025 · Dec 31, 2023 −$151.76M
Operating Income Q3 2025 · Sep 30, 2025 −$90.24M
Operating Income Q3 2025 · Sep 30, 2025 −$251.99M
Operating Income Q3 2025 · Sep 30, 2024 −$81.7M
Operating Income Q3 2025 · Sep 30, 2024 −$207.4M